184 related articles for article (PubMed ID: 29061059)
21. Pancreatic neuroendocrine tumours.
Alexakis N; Neoptolemos JP
Best Pract Res Clin Gastroenterol; 2008; 22(1):183-205. PubMed ID: 18206821
[TBL] [Abstract][Full Text] [Related]
22. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Diel IJ; Solomayer EF; Bastert G
Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
[TBL] [Abstract][Full Text] [Related]
23. Contemporary management of metastatic bone disease: tips and tools of the trade for general practitioners.
Quinn RH; Randall RL; Benevenia J; Berven SH; Raskin KA
J Bone Joint Surg Am; 2013 Oct; 95(20):1887-95. PubMed ID: 24288805
[No Abstract] [Full Text] [Related]
24. Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitors.
Scher HI; Yagoda A
Am J Med; 1987 Feb; 82(2A):6-28. PubMed ID: 3548343
[TBL] [Abstract][Full Text] [Related]
25. Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysis.
Garcia-Torralba E; Spada F; Lim KHJ; Jacobs T; Barriuso J; Mansoor W; McNamara MG; Hubner RA; Manoharan P; Fazio N; Valle JW; Lamarca A
Cancer Treat Rev; 2021 Mar; 94():102168. PubMed ID: 33730627
[TBL] [Abstract][Full Text] [Related]
26. Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials.
LeVasseur N; Clemons M; Hutton B; Shorr R; Jacobs C
Cancer Treat Rev; 2016 Nov; 50():183-193. PubMed ID: 27716496
[TBL] [Abstract][Full Text] [Related]
27. The multidisciplinary approach to bone metastases.
Blum RH; Novetsky D; Shasha D; Fleishman S
Oncology (Williston Park); 2003 Jun; 17(6):845-57; discussion 862-3, 867. PubMed ID: 12846127
[TBL] [Abstract][Full Text] [Related]
28. Managing skeletal related events resulting from bone metastases.
Wilkinson AN; Viola R; Brundage MD
BMJ; 2008 Nov; 337():a2041. PubMed ID: 18981017
[No Abstract] [Full Text] [Related]
29. Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.
Putzer D; Gabriel M; Henninger B; Kendler D; Uprimny C; Dobrozemsky G; Decristoforo C; Bale RJ; Jaschke W; Virgolini IJ
J Nucl Med; 2009 Aug; 50(8):1214-21. PubMed ID: 19617343
[TBL] [Abstract][Full Text] [Related]
30. [Bisphosphonate treatment against breast cancer with bone metastases].
Kohno N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
[No Abstract] [Full Text] [Related]
31. [Bone metastases].
Jensen AB; Kamby C; Hansen B; Keller J
Ugeskr Laeger; 2007 Oct; 169(44):3753-6. PubMed ID: 18028842
[TBL] [Abstract][Full Text] [Related]
32. Evaluating bone metastases.
Albert K
Clin J Oncol Nurs; 2007 Apr; 11(2):193-7. PubMed ID: 17573268
[No Abstract] [Full Text] [Related]
33. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
34. Approach to the thyroid cancer patient with extracervical metastases.
Haugen BR; Kane MA
J Clin Endocrinol Metab; 2010 Mar; 95(3):987-93. PubMed ID: 20203334
[TBL] [Abstract][Full Text] [Related]
35. Advances in prevention and treatment of bone metastases in prostate cancer. Role of RANK/RANKL inhibition.
Gomez-Veiga F; Ponce-Reixa J; Martinez-Breijo S; Planas J; Morote J
Actas Urol Esp; 2013 May; 37(5):292-304. PubMed ID: 23246105
[TBL] [Abstract][Full Text] [Related]
36. [Current use of bisphosphonates in clinical oncology].
Vrbanec D; Plestina S; Belev B; Unusić J; Pavlinić-Diminić V
Lijec Vjesn; 1999; 121(9-10):296-301. PubMed ID: 19658372
[TBL] [Abstract][Full Text] [Related]
37. Treatment of bone metastases in urologic malignancies.
Froehner M; Hölscher T; Hakenberg OW; Wirth MP
Urol Int; 2014; 93(3):249-56. PubMed ID: 25115989
[TBL] [Abstract][Full Text] [Related]
38. Bone continuum of cancer.
Lipton A
Am J Clin Oncol; 2010 Jun; 33(3 Suppl):S1-7. PubMed ID: 20526089
[TBL] [Abstract][Full Text] [Related]
39. [Clinical features and prognosis in 104 colorectal cancer patients with bone metastases].
Hong RX; Lin QJ; Luo J; Dai Z; Wang WN
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):787-91. PubMed ID: 24378104
[TBL] [Abstract][Full Text] [Related]
40. [Symptom with bone metastasis--bone pain, fracture, hypercalcemia].
Toyoshi H
Nihon Rinsho; 2007 Jan; 65(1):76-81. PubMed ID: 17233419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
